Search
Search Results
##search.searchResults.foundPlural##
-
Safety warning for ChAdOx1 nCov-19 vaccine in patients with sickle cell disease Astra Zeneca vaccine in Sickle cell disease (SCD)
2001PDF: 454HTML: 116 -
PROGNOSTIC FACTORS IN HODGKIN LYMPHOMA
3175PDF: 1909HTML: 7452 -
PATHOGENESIS OF MALARIA IN TISSUES AND BLOOD
4329PDF: 1863HTML: 17709 -
TREATMENT OF INDOLENT AND ADVANCED SYSTEMIC MASTOCYTOSIS Systemic Mastocytosis Treatment
1968PDF: 1458HTML: 258 -
How we manage invasive fungal disease in acute myeloid leukemia patients with Glucose 6 Dehydrogenase deficiency
1773PDF: 878HTML: 930Referring article: 715 -
A retrospective descriptive study characterizing coronavirus disease epidemiology among people in the Kurdistan Region, Iraq Characterization of COVID-19 in Kurdistan Region, Iraq
1126PDF: 797HTML: 211 -
IMPACT OF COVID-19 ON OUTCOMES OF PATIENTS WITH HEMATOLOGIC MALIGNANCIES: A MULTI-CENTER, RETROSPECTIVE STUDY COVID-19 and hematologic malignancy
1351PDF: 718HTML: 191 -
CONCISE REVIEW ON THE FREQUENCY, MAJOR RISK FACTORS AND SURVEILLANCE OF HEPATOCELLULAR CARCINOMA (HCC) IN ?-THALASSEMIAS: PAST, PRESENT AND FUTURE PERSPECTIVES Thalassaemia transfusion dependent, Hepatitis C, hepatocarcinoma.
4127PDF: 1486HTML: 426 -
Seroprevalence of anti SARS-CoV2 antibodies in Umbrian persons living with HIV SARS-CoV-2 and HIV
845PDF: 758HTML: 224 -
CLINICAL AND HEMATOLOGICAL PROFILE OF PATIENTS WITH DENGUE FEVER AT A TERTIARY CARE HOSPITAL – AN OBSERVATIONAL STUDY
4074PDF: 1697HTML: 458Figure 1: Age distribution of Pediatric cases: 193 -
-
SOCIOECONOMIC STATUS IS GLOBALLY A PROGNOSTIC FACTOR FOR OVERALL SURVIVAL OF MULTIPLE MYELOMA PATIENTS; SYNTHESIS OF STUDIES AND REVIEW OF THE LITERATURE SES as prognostic factor for myeloma survival
1950PDF: 776HTML: 195 -
DISSEMINATED HISTOPLASMOSIS IN IMMUNOCOMPETENT INDIVIDUALS- NOT A SO RARE ENTITY
2308PDF: 1072HTML: 2147Untitled: 141 -
AGE AT DIAGNOSIS OF SICKLE CELL ANAEMIA IN LAGOS, NIGERIA
1921PDF: 864HTML: 1848 -
END-OF-LIFE CARE IN SICKLE CELL DISEASE AND TRASFUSION DEPENDEND-β-THALASSEMIA: CLINICAL, PSYCHOLOGICAL, AND ETHICAL CONSIDERATION Challenges in Supportive Care, Equity, and Compassion at End of Life
888PDF: 532Html: 146 -
DISSEMINATED HISTOPLASMOSIS AS AIDS PRESENTATION. CASE REPORT AND COMPREHENSIVE REVIEW OF CURRENT LITERATURE
3549PDF: 1250HTML: 701Figure 2: 422Figure 1: 3088 -
WHAT UNRELATED HEMATOPOIETIC STEM CELL TRANSPLANTATION IN THALASSEMIA TAUGHT US ABOUT TRANSPLANT IMMUNOGENETICS.
3090PDF: 1099HTML: 1453Untitled: 159Untitled: 147Untitled: 147 -
ADVANCES IN THE TREATMENT OF MALARIA
2778PDF: 1091HTML: 5976 -
AN OBSERVATIONAL STUDY OF THE EFFECT OF HEMOGLOBINOPATHY, ALPHA THALASSEMIA AND HEMOGLOBIN E ON P. VIVAX PARASITEMIA
2676PDF: 848HTML: 360Distribution of malaria patient cohort along Thailand and borders during 2011-2012: 176 -
Severe Acute Hepatitis B Treated with Entecavir
1448PDF: 739HTML: 2451Figure: 149Title page: 155disclosure: 91 -
ASSESSMENT OF THE EFFICACY OF PROCALCITONIN, C-REACTIVE PROTEIN AND ALBUMIN LEVELS-GUIDED ANTIBIOTICS USE IN SEPSIS
860PDF: 439Html: 128Suppl. Files: 146 -
Monocyte HLA-Dr Expression to Monitor Immune Response and Potential Infection Risks Following Vaso-Occlusive Crises in Patients with Sickle Cell Anemia Monocyte HLA-DR expression in SCA patients
618PDF: 481HTML: 199 -
MILD BLEEDERS: DIAGNOSIS IS ELUSIVE IN LARGE NUMBER OF PATIENTS
3249PDF: 688HTML: 700Figure 1 Distribution of the various causes of mild bleeding (in %) in males and females: 163Figure 2 Age and Sex distribution of patients with Bleeding disorders- Unclassified: 159Table : Distribution of the sites of bleeding and their causes: 163 -
Coronavirus disease 2019 (COVID-19) severity in patients with thalassemias: A Nationwide Iranian Experience Coronavirus in patients with thalassemias
1280PDF: 430HTML: 151







